ovarian cancer |
Up |
Promote cell proliferation, migration, and invasion, and inhibit apoptosis |
Promote miR-126-5p maturation by increasing the degree of m6A modification of pri-miR-126-5pmRNA and facilitate tumorigenesis and migration through the PTEN/PI3K/AKT3/mTOR axis |
Bi et al. (2021a)
|
Up |
Promote proliferation, migration, invasion, and inhibition of apoptosis |
Promote the conversion of pre-miR-1246 to mature miR-1246 mRNA, and miR-1246 targets CCNG2 and inhibits its expression |
Bi et al. (2021b)
|
Up |
Promote cell proliferation and migration, and inhibit cell apoptosis |
As an independent factor affecting ovarian cancer prognosis and correlated with ovarian cancer-associated oncogene m6A enrichment |
Ma et al. (2020)
|
Up |
Promote migration and invasion |
Stabilize TRPC3 mRNA expression via m6A modification |
Shen et al. (2022b)
|
Up |
Promote cell proliferation, tumor growth, and invasion |
Stimulate AXL translation and EMT |
Hua et al. (2018)
|
Up |
Inhibit cell apoptosis and promote the cell cycle |
Increase the level of KRT8, and decrease the level of FAS |
Yang et al. (2022)
|
Up |
Inhibit cell apoptosis and promote invasion |
Increase activation of the AKT signaling pathway and the expression of the downstream effector Cyclin D1 |
Liang et al. (2020b)
|
Up |
Promote cell growth and development, metastasis and invasion, and weaken cisplatin sensitivity |
Mettl3/YTHDF2 axis represses tumor suppressor gene IFFO1 expression and promotes mRNA degradation |
Zhang et al. (2023)
|